Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice

Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension

(2013) Gérald Simonneau   ANNALS OF INTERNAL MEDICINE

Multi-drug Resistance Protein 4 (MRP4/ABCC4) and cyclic nucleotides signaling pathways

(2011) Yassine Sassi et al.   CELL CYCLE

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

(2010) Marc Humbert et al.   CIRCULATION

Novel Strategy for Treatment of Pulmonary Arterial Hypertension: Enhancement of Apoptosis

(2010) Jing-bin Huang et al.   LUNG

Emerging therapies for the treatment of pulmonary hypertension

(2010) Kurt R. Stenmark et al.   Pediatric Critical Care Medicine

Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors

(2009) E. Delannoy et al.   CARDIOVASCULAR RESEARCH

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Simvastatin and sildenafil combine to attenuate pulmonary hypertension

(2009) L. Zhao et al.   EUROPEAN RESPIRATORY JOURNAL

Future Perspectives for the Treatment of Pulmonary Arterial Hypertension

(2009) Hossein A. Ghofrani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

(2009) Paul M. Hassoun et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension

(2009) Stephen L. Archer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synergy between Natriuretic Peptides and Phosphodiesterase 5 Inhibitors Ameliorates Pulmonary Arterial Hypertension

(2008) Reshma S. Baliga et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Multidrug Resistance Protein-1 Affects Oxidative Stress, Endothelial Dysfunction, and Atherogenesis via Leukotriene C 4 Export

(2008) Cornelius F.H. Mueller et al.   CIRCULATION

Interleukin-6 Overexpression Induces Pulmonary Hypertension

(2008) M. Kathryn Steiner et al.   CIRCULATION RESEARCH

Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs

(2008) Lena Oevermann et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular pathogenesis of pulmonary arterial hypertension

(2008) Marlene Rabinovitch   JOURNAL OF CLINICAL INVESTIGATION

Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation

(2008) Yassine Sassi et al.   JOURNAL OF CLINICAL INVESTIGATION